The Clinical Letter is:

A monthly reference on clinical trials, with regular features on newly opened cancer center trials, industry-sponsored studies, and NCI cooperative group trials. Benefit to the advertiser: Catch the eye of prospects by placing your advertising side-by-side with dynamic content that readers refer to regularly. Advertise to potential principle investigators and others interested in clinical trials.

A succinct source of information on research results, including coverage of presentations at oncology conferences. Benefit to the advertiser: Prospects will associate the value of the insights gained from reports on advances in oncology treatment with your offering, leveraging the "must-read" atmosphere of the reports into positive regard for your offering. You can time your advertising to coincide with oncology conferences, knowing that coverage of those meetings will be included in the newsletter.

Delivered electronically via Adobe PDF to most readers. Benefit to the advertiser: Your ad will reach the coveted space of the "In Box" of key leaders and influential players in oncology. Your ad can include clickable links to Web pages or email addresses, providing a fast way to establish a direct relationship with prospects.

Flexible and fast in responding to your advertising needs. Although a monthly, The Clinical Cancer Letter does not require long lead times for placement or changes to advertising. Benefit to the advertiser: The ability to customize or change messages as needed shows your prospects that you are current and responsive. It also allows you to refine your message as the market changes.